Aprea Therapeutics Inc Stock Ownership - Who owns Aprea Therapeutics?

Insider buying vs selling

Have Aprea Therapeutics Inc insiders been buying or selling?
Bernd R. SeizingerDirector2023-06-076,029$3.68
Bernd R. SeizingerDirector2023-06-064,068$3.63
John P. HamillSrVPCFOPrin Fin Acct Ofcr2023-02-271,000$5.25

1 of 1

APRE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APRE insiders and whales buy or sell their stock.

APRE Shareholders

What type of owners hold Aprea Therapeutics Inc stock?
Tryant LLC749.33%28,000,000$116.20MInsider
Thomas Banks358.37%13,391,146$55.57MInsider
Frank J. Hall127.97%4,781,889$19.84MInsider
David West Wilson78.27%2,924,726$12.14MInsider
Heidi A. Patterson71.94%2,688,221$11.16MInsider
Kdev Investments Ab53.33%1,992,586$8.27MInsider
Michael Reynolds52.99%1,980,040$8.22MInsider
Redmile Group LLC47.33%1,768,718$7.34MInsider
Aigh Capital Management LLC9.35%349,300$1.45MInstitution
Oren Gilad8.64%322,770$1.34MInsider

1 of 3

APRE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APRE1.46%98.54%Net Buying
HARP36.77%63.23%Net Buying
GLTO37.60%24.86%Net SellingNet Selling
VBIV2.92%97.08%Net SellingNet Buying

Aprea Therapeutics Stock Ownership FAQ

Who owns Aprea Therapeutics?

Aprea Therapeutics (NASDAQ: APRE) is owned by 23.58% institutional shareholders, 1,586.76% Aprea Therapeutics insiders, and 0.00% retail investors. Tryant LLC is the largest individual Aprea Therapeutics shareholder, owning 28.00M shares representing 749.33% of the company. Tryant LLC's Aprea Therapeutics shares are currently valued at $116.20M.

If you're new to stock investing, here's how to buy Aprea Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.